Daniel Wegener
Overview
Explore the profile of Daniel Wegener including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
120
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Murr M, Wegener D, Boke S, Gani C, Monnich D, Niyazi M, et al.
Phys Imaging Radiat Oncol
. 2024 Nov;
32:100662.
PMID: 39554802
Background And Purpose: Conventional image-guided radiotherapy (conv-IGRT) is standard in prostate cancer (PC) but does not account for inter-fraction anatomical changes. Online-adaptive magnetic resonance-guided RT (OA-MRgRT) may improve organ-at-risk (OARs)...
2.
Potkrajcic V, Gani C, Fischer S, Boeke S, Niyazi M, Thorwarth D, et al.
Curr Oncol
. 2024 May;
31(5):2679-2688.
PMID: 38785484
The use of hypofractionated radiotherapy in prostate cancer has been increasingly evaluated, whereas accumulated evidence demonstrates comparable oncologic outcomes and toxicity rates compared to normofractionated radiotherapy. In this prospective study,...
3.
Wegener D, Perez-Bitrian A, Limberg N, Wiesner A, Hoffmann K, Riedel S
Chemistry
. 2024 Apr;
30(36):e202401231.
PMID: 38625061
Lewis acidic boron compounds are ubiquitous in chemistry due to their numerous applications, yet tuning and optimizing their properties towards different purposes is still a challenging field of research. In...
4.
Tengler B, Kunzel L, Hagmuller M, Monnich D, Boeke S, Wegener D, et al.
Phys Imaging Radiat Oncol
. 2024 Feb;
29:100534.
PMID: 38298884
Background And Purpose: Daily online treatment plan adaptation requires a fast workflow and planning process. Current online planning consists of adaptation of a predefined reference plan, which might be suboptimal...
5.
Fink C, Wegener D, Sauer L, Lentz-Hommertgen A, Liermann J, Muller A, et al.
Int J Radiat Oncol Biol Phys
. 2023 Oct;
118(4):1011-1017.
PMID: 37863242
Purpose: After radical prostatectomy (RP), adjuvant or salvage radiation treatment in node-positive prostate cancer is offered to prevent systemic disease. Prospective long-term survival and toxicity data on patients with radiation...
6.
Perez-Bitrian A, Munarriz J, Sturm J, Wegener D, Krause K, Wiesner A, et al.
Inorg Chem
. 2023 Jul;
62(32):12947-12953.
PMID: 37505485
The pentafluoroorthotellurate group (teflate, OTeF) is considered as a bulky analogue of fluoride, yet its coordination behavior in transition metal complexes is not fully understood. By reaction of [CoCl] and...
7.
Almansour H, Schick F, Nachbar M, Afat S, Fritz V, Thorwarth D, et al.
Radiol Oncol
. 2023 Jun;
57(2):184-190.
PMID: 37341194
Background: Hybrid MRI linear accelerators (MR-Linac) might enable individualized online adaptation of radiotherapy using quantitative MRI sequences as diffusion-weighted imaging (DWI). The purpose of this study was to investigate the...
8.
Nachbar M, Lo Russo M, Gani C, Boeke S, Wegener D, Paulsen F, et al.
Z Med Phys
. 2023 Jun;
34(2):197-207.
PMID: 37263911
Background And Purpose: MR-guided radiotherapy (MRgRT) online plan adaptation accounts for tumor volume changes, interfraction motion and thus allows daily sparing of relevant organs at risk. Due to the high...
9.
Lo Russo M, Nachbar M, Barry A, Bhide S, Chang A, Hall W, et al.
Clin Transl Radiat Oncol
. 2022 Oct;
38:1-5.
PMID: 36299279
Background: Online adaptive MR-guided radiotherapy allows for the reduction of safety margins in dose escalated treatment of rectal tumors. With the use of smaller margins, precise tumor delineation becomes more...
10.
Wegener D, Aebersold D, Grimm M, Hammerer P, Froehner M, Graefen M, et al.
Biomedicines
. 2022 Sep;
10(9).
PMID: 36140357
Results of three randomized clinical trials (RCTs) comparing adjuvant radiotherapy (ART) and early salvage radiotherapy (eSRT) of prostate carcinoma and a subsequent meta-analysis of the individual patient data from these...